Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ahmed El-Gazzar

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Bone Reports|August 12, 2021
A novel cryptic splice site mutation in <i>COL1A2</i> as a cause of osteogenesis imperfectaAhmed El-Gazzar, Johannes A Mayr, Barbara Voraberger, et al.
Leukemia & Lymphoma|September 25, 2014
The potential evasion of immune surveillance in mucosa associated lymphoid tissue lymphoma by DcR2-mediated up-regulation of nuclear factor-κBMariam Anees, Peter Horak, Ana-Iris Schiefer, et al.
Molecular Cancer Therapeutics|April 8, 2010
Natural immunity enhances the activity of a DR5 agonistic antibody and carboplatin in the treatment of ovarian cancerAhmed El-Gazzar, Paul Perco, Eva Eckelhart, et al.
Bone Reports|July 25, 2022
<i>SMAD3</i> mutation in LDS3 causes bone fragility by impairing the TGF-β pathway and enhancing osteoclastogenesisAhmed El-Gazzar, Heeseog Kang, Nadja Fratzl-Zelman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 22, 2011
hVps37A Status affects prognosis and cetuximab sensitivity in ovarian cancerMichael Wittinger, Petr Vanhara, Ahmed El-Gazzar, et al.
Frontiers in Endocrinology|July 17, 2023
Investigating the role of ASCC1 in the causation of bone fragilityBarbara Voraberger, Johannes A Mayr, Nadja Fratzl-Zelman, et al.
Oncoimmunology|January 18, 2021
Live-attenuated lymphocytic choriomeningitis virus-based vaccines for active immunotherapy of HPV16-positive cancerSarah Schmidt, Weldy V Bonilla, Andrea Reiter, et al.
EMBO Molecular Medicine|March 14, 2023
Bi-allelic mutation in SEC16B alters collagen trafficking and increases ER stressAhmed El-Gazzar, Barbara Voraberger, Frank Rauch, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 26, 2022
High Bone Mass Disorders: New Insights From Connecting the Clinic and the BenchDylan J M Bergen, Antonio Maurizi, Melissa M Formosa, et al.
Bone|October 28, 2023
The Global ALPL gene variant classification project: Dedicated to deciphering variantsMariam R Farman, Catherine Rehder, Theodora Malli, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Bone Reports|August 12, 2021
A novel cryptic splice site mutation in <i>COL1A2</i> as a cause of osteogenesis imperfectaAhmed El-Gazzar, Johannes A Mayr, Barbara Voraberger, et al.
Leukemia & Lymphoma|September 25, 2014
The potential evasion of immune surveillance in mucosa associated lymphoid tissue lymphoma by DcR2-mediated up-regulation of nuclear factor-κBMariam Anees, Peter Horak, Ana-Iris Schiefer, et al.
Molecular Cancer Therapeutics|April 8, 2010
Natural immunity enhances the activity of a DR5 agonistic antibody and carboplatin in the treatment of ovarian cancerAhmed El-Gazzar, Paul Perco, Eva Eckelhart, et al.
Bone Reports|July 25, 2022
<i>SMAD3</i> mutation in LDS3 causes bone fragility by impairing the TGF-β pathway and enhancing osteoclastogenesisAhmed El-Gazzar, Heeseog Kang, Nadja Fratzl-Zelman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 22, 2011
hVps37A Status affects prognosis and cetuximab sensitivity in ovarian cancerMichael Wittinger, Petr Vanhara, Ahmed El-Gazzar, et al.
Frontiers in Endocrinology|July 17, 2023
Investigating the role of ASCC1 in the causation of bone fragilityBarbara Voraberger, Johannes A Mayr, Nadja Fratzl-Zelman, et al.
Oncoimmunology|January 18, 2021
Live-attenuated lymphocytic choriomeningitis virus-based vaccines for active immunotherapy of HPV16-positive cancerSarah Schmidt, Weldy V Bonilla, Andrea Reiter, et al.
EMBO Molecular Medicine|March 14, 2023
Bi-allelic mutation in SEC16B alters collagen trafficking and increases ER stressAhmed El-Gazzar, Barbara Voraberger, Frank Rauch, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 26, 2022
High Bone Mass Disorders: New Insights From Connecting the Clinic and the BenchDylan J M Bergen, Antonio Maurizi, Melissa M Formosa, et al.
Bone|October 28, 2023
The Global ALPL gene variant classification project: Dedicated to deciphering variantsMariam R Farman, Catherine Rehder, Theodora Malli, et al.
Pageof 3